ALLIX Fundamental Analysis - WALLIX GROUP

Fundamental Rating

Overall ALLIX gets a fundamental rating of 2 out of 10. We evaluated ALLIX against 115 industry peers in the Software industry. Both the profitability and financial health of ALLIX have multiple concerns. While showing a medium growth rate, ALLIX is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALLIX had negative earnings in the past year.

ALLIX had a positive operating cash flow in the past year.

In the past 5 years ALLIX always reported negative net income.

The reported operating cash flow has been mixed in the past 5 years: ALLIX reported negative operating cash flow in multiple years.

1.2 Ratios

ALLIX's Return On Assets of -3.53% is on the low side compared to the rest of the industry. ALLIX is outperformed by 65.22% of its industry peers.

Looking at the Return On Equity, with a value of -24.56%, ALLIX is doing worse than 75.65% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-3.53%
ROE	-24.56%
ROIC	N/A

ROA(3y)-11.47%

ROA(5y)-10.77%

ROE(3y)-44.92%

ROE(5y)-35.34%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ALLIX has a Gross Margin of 108.52%. This is amongst the best in the industry. ALLIX outperforms 98.26% of its industry peers.

In the last couple of years the Gross Margin of ALLIX has remained more or less at the same level.

The Profit Margin and Operating Margin are not available for ALLIX so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	108.52%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.14%

GM growth 5Y-0.06%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALLIX does not have a ROIC to compare to the WACC, probably because it is not profitable.

ALLIX has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.22, we must say that ALLIX is in the distress zone and has some risk of bankruptcy.

ALLIX has a worse Altman-Z score (1.22) than 66.96% of its industry peers.

ALLIX has a Debt/Equity ratio of 1.07. This is a high value indicating a heavy dependency on external financing.

ALLIX has a worse Debt to Equity ratio (1.07) than 80.87% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	1.07
Debt/FCF	N/A
Altman-Z	1.22

ROIC/WACCN/A

WACC8.43%

2.3 Liquidity

ALLIX has a Current Ratio of 0.79. This is a bad value and indicates that ALLIX is not financially healthy enough and could expect problems in meeting its short term obligations.

With a Current ratio value of 0.79, ALLIX is not doing good in the industry: 84.35% of the companies in the same industry are doing better.

ALLIX has a Quick Ratio of 0.79. This is a bad value and indicates that ALLIX is not financially healthy enough and could expect problems in meeting its short term obligations.

ALLIX has a worse Quick ratio (0.79) than 83.48% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.79
Quick Ratio	0.79

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 79.11% over the past year.

Looking at the last year, ALLIX shows a quite strong growth in Revenue. The Revenue has grown by 17.72% in the last year.

Measured over the past years, ALLIX shows a quite strong growth in Revenue. The Revenue has been growing by 15.85% on average per year.

EPS 1Y (TTM)79.11%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%45.98%

Revenue 1Y (TTM)17.72%

Revenue growth 3Y13.73%

Revenue growth 5Y15.85%

Sales Q2Q%18.89%

3.2 Future

The Earnings Per Share is expected to grow by 62.60% on average over the next years. This is a very strong growth

Based on estimates for the next years, ALLIX will show a very strong growth in Revenue. The Revenue will grow by 22.11% on average per year.

EPS Next Y103.9%

EPS Next 2Y74.7%

EPS Next 3Y62.6%

EPS Next 5YN/A

Revenue Next Year21.15%

Revenue Next 2Y21.78%

Revenue Next 3Y22.11%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALLIX. In the last year negative earnings were reported.

The Price/Forward Earnings ratio is 27.21, which means the current valuation is very expensive for ALLIX.

The rest of the industry has a similar Price/Forward Earnings ratio as ALLIX.

When comparing the Price/Forward Earnings ratio of ALLIX to the average of the S&P500 Index (24.01), we can say ALLIX is valued inline with the index average.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	27.21

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALLIX is valued a bit more expensive than the industry average as 60.87% of the companies are valued more cheaply.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	48.38

4.3 Compensation for Growth

ALLIX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

ALLIX's earnings are expected to grow with 62.60% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y74.7%

EPS Next 3Y62.6%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALLIX!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

WALLIX GROUP

EPA:ALLIX (12/22/2025, 7:00:00 PM)

22.7

+0.5 (+2.25%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustrySoftware

Earnings (Last)11-03 2025-11-03

Earnings (Next)03-18 2026-03-18/amc

Inst Owners10.83%

Inst Owner ChangeN/A

Ins Owners19.72%

Ins Owner ChangeN/A

Market Cap153.00M

Revenue(TTM)36.95M

Net Income(TTM)-1.80M

Analysts84

Price Target31.11 (37.05%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)35.56%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)-50%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0.61%

Revenue NY rev (3m)-0.6%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	27.21
P/S	4.14
P/FCF	N/A
P/OCF	37.05
P/B	19.12
P/tB	N/A
EV/EBITDA	48.38

EPS(TTM)-0.28

EYN/A

EPS(NY)0.83

Fwd EY3.68%

FCF(TTM)-0.42

FCFYN/A

OCF(TTM)0.61

OCFY2.7%

SpS5.48

BVpS1.19

TBVpS-1.82

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-3.53%
ROE	-24.56%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	108.52%
FCFM	N/A

ROA(3y)-11.47%

ROA(5y)-10.77%

ROE(3y)-44.92%

ROE(5y)-35.34%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.14%

GM growth 5Y-0.06%

F-Score5

Asset Turnover0.72

Health

		Industry Rank	Sector Rank
Debt/Equity	1.07
Debt/FCF	N/A
Debt/EBITDA	2.35
Cap/Depr	121.43%
Cap/Sales	18.86%
Interest Coverage	N/A
Cash Conversion	124.02%
Profit Quality	N/A
Current Ratio	0.79
Quick Ratio	0.79
Altman-Z	1.22

F-Score5

WACC8.43%

ROIC/WACCN/A

Cap/Depr(3y)134.6%

Cap/Depr(5y)153.57%

Cap/Sales(3y)19.1%

Cap/Sales(5y)22.25%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)79.11%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%45.98%

EPS Next Y103.9%

EPS Next 2Y74.7%

EPS Next 3Y62.6%

EPS Next 5YN/A

Revenue 1Y (TTM)17.72%

Revenue growth 3Y13.73%

Revenue growth 5Y15.85%

Sales Q2Q%18.89%

Revenue Next Year21.15%

Revenue Next 2Y21.78%

Revenue Next 3Y22.11%

Revenue Next 5YN/A

EBIT growth 1Y75.02%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year144.36%

EBIT Next 3Y66.73%

EBIT Next 5YN/A

FCF growth 1Y50.26%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y548.91%

OCF growth 3Y-37.14%

OCF growth 5YN/A

WALLIX GROUP / ALLIX.PA FAQ

What is the ChartMill fundamental rating of WALLIX GROUP (ALLIX.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALLIX.PA.

Can you provide the valuation status for WALLIX GROUP?

ChartMill assigns a valuation rating of 2 / 10 to WALLIX GROUP (ALLIX.PA). This can be considered as Overvalued.

What is the profitability of ALLIX stock?

WALLIX GROUP (ALLIX.PA) has a profitability rating of 2 / 10.

WALLIX GROUP (ALLIX.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

WALLIX GROUP / ALLIX.PA FAQ

What is the ChartMill fundamental rating of WALLIX GROUP (ALLIX.PA) stock?

Can you provide the valuation status for WALLIX GROUP?

What is the profitability of ALLIX stock?